G Canepa

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini et al. · European Urology · 2016 · 235 citations

Surgical Oncology, Urology, Genitourinary Cancer +6

Short-Schedule Intravesical Gemcitabine with Ablative Intent in Recurrent Ta–T1, G1–G2, Low- or Intermediate-Risk, Transitional Cell Carcinoma of the Bladder

Massimo Maffezzini, Fabio Campodonico, G Canepa et al. · European Urology · 2006 · 37 citations

Ablative Intent, Urology, Surgical Oncology +9

Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy

U. Tunn, G Canepa, A Kochanowsky et al. · Prostate Cancer and Prostatic Diseases · 2012 · 35 citations

Andrology, Urology, Off-treatment Time +2

Prognostic significance of fluorescent in situ hybridisation in the follow-up of non-muscle-invasive bladder cancer.

Massimo Maffezzini, Fabio Campodonico, Giacomo Capponi et al. · PubMed · 2010 · 30 citations

Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma <i>in Situ</i> of the Urinary Bladder: A Retrospective Multicentre Study

F. Johannes P. van Valenberg, Amir Kajtazovic, G Canepa et al. · Bladder Cancer · 2018 · 26 citations · Full text